|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017976,
umls-concept:C0022262,
umls-concept:C0024485,
umls-concept:C0205314,
umls-concept:C0220781,
umls-concept:C0679622,
umls-concept:C0868955,
umls-concept:C1707689,
umls-concept:C1883254,
umls-concept:C1999216,
umls-concept:C2603343
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1999-8-19
|
|
pubmed:abstractText |
N-13C-methyl-deoxynojirimycin was synthesized and used in isotope-edited NMR studies to probe the binding site of an alpha-glucosidase. Results from this analysis led to the design and preparation of a novel alpha-glucosidase inhibitor, N-glycyl deoxynojirimycin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0960-894X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1255-60
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Isotope edited NMR studies of glycosidases: design and synthesis of a novel glycosidase inhibitor.
|
|
pubmed:affiliation |
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University, Columbus 43210, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
